[Adenoviral-mediated expression of PTEN cDNA induces apoptosis in endometrial carcinoma cells].
Yang, Pei-li; Liu, Yu-huan; Cui, Ying; Cai, Zai-long; Mao, Ji-fang.
Zhonghua Fu Chan Ke Za Zhi
; 41(8): 549-53, 2006 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-17083842
Class I Phosphoinositide 3-Kinase <i>PIK3CA</i>/p110α and <i>PIK3CB</i>/p110ß Isoforms in Endometrial Cancer.
Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: endometrial cancer as a model.
Impact of age at diagnosis on racial disparities in endometrial cancer patients.
LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma.
Classification of endometrial carcinoma: more than two types.
A clinically applicable molecular-based classification for endometrial cancers.
Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing.
LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells.
Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas.
Differential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas.